AstraZeneca PLC (OTCMKTS:AZNCF) Sees Significant Decrease in Short Interest

AstraZeneca PLC (OTCMKTS:AZNCF) was the recipient of a significant drop in short interest in the month of March. As of March 15th, there was short interest totalling 320,500 shares, a drop of 28.2% from the February 28th total of 446,500 shares. Based on an average daily volume of 3,200 shares, the short-interest ratio is presently 100.2 days.

AstraZeneca Stock Up 5.3 %

OTCMKTS AZNCF opened at $147.47 on Friday. AstraZeneca has a 1-year low of $120.64 and a 1-year high of $175.00. The stock’s 50 day moving average is $146.58 and its two-hundred day moving average is $142.79.

AstraZeneca Increases Dividend

The business also recently disclosed a dividend, which was paid on Monday, March 24th. Shareholders of record on Friday, February 21st were paid a dividend of $2.10 per share. This is a positive change from AstraZeneca’s previous dividend of $1.00. The ex-dividend date of this dividend was Wednesday, February 19th. AstraZeneca’s dividend payout ratio is currently 343.14%.

About AstraZeneca

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology.